Valneva SE (AYJ)
FSX
Real-time Data
06:00 AM
Day's Range
2.2452 wk Range
2.14Overview - AYJ - Valneva SE
Key Statistics
Valuation
Enterprise Value
651.57M
P/E (Trailing)
‪73.99‬
PEG Ratio
‪0.36‬
Price / Sales (TTM)
‪3.93‬
Price / Book
‪6.93‬
EV / EBITDA
‪-6.60‬
Profitability
Gross Margin
‪15.28%‬
Profit Margin
‪-110.29%‬
Operating Margin
‪-74.91%‬
Return on Assets
‪-16.68%‬
Return on Equity
‪-117.84%‬
Ownership
Shares Outstanding
173.75M
Float
157.26M
Held by Insiders
‪10.72%‬
Held by Institutions
‪24.41%‬
Price stats
Beta
‪1.34‬
50-Day Avg
‪2.34‬
200-Day Avg
‪3.21‬
Dividends
Payout Ratio
‪0.00%‬
Peers - AYJ - Valneva SE
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- AYJFSXValneva SE434.62MMarket Cap-24.91%52-week change74.00P/E (Trailing)‪-88.29%‬Profit Margin
- ANLFSXAnalog Devices, Inc.152.94BMarket Cap+29.62%52-week change44.47P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE56.27BMarket Cap+30.57%52-week change39.07P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.72BMarket Cap+33.14%52-week change39.13P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.50.02BMarket Cap+81.89%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 42ZFSXRevolution Medicines Inc.37.93BMarket Cap+83.17%52-week change-30.35P/E (Trailing)‪0.00%‬Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.29BMarket Cap+16.03%52-week change65.41P/E (Trailing)‪10.69%‬Profit Margin
Profile Summary - AYJ - Valneva SE
About
Valneva SE is a specialty vaccine company headquartered in Saint-Herblain, France, that develops, manufactures, and commercializes prophylactic vaccines targeting infectious diseases with significant unmet medical needs. Its commercial portfolio features three key vaccines: IXIARO®, for Japanese encephalitis;…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
